We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$6.5B
AUM Growth
+$106M
Cap. Flow
-$484M
Cap. Flow %
-7.44%
Top 10 Hldgs %
52.66%
Holding
925
New
127
Increased
448
Reduced
289
Closed
61

Sector Composition

Rank Sector Weight
1 Financials 12.12%
2 Technology 8.06%
3 Healthcare 5.67%
4 Energy 5.37%
5 Real Estate 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRCI
551
DELISTED
SRC Energy Inc
SRCI
$1.01M 0.02%
244,750
-84,137
-26% -$319K
BLD
552
DELISTED
TopBuild
BLD
$997K 0.02%
9,676
+855
+10% +$89K
GTHX
553
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$995K 0.02%
37,648
-11,557
-23% -$270K
UNM icon
554
Unum
UNM
$13.4B
$986K 0.02%
33,805
+2,315
+7% +$67.3K
SAFE
555
DELISTED
Safehold Inc.
SAFE
$978K 0.02%
+24,276
New +$890K
SPR
556
DELISTED
Spirit AeroSystems
SPR
$976K 0.02%
13,396
+1,588
+13% +$131K
VKTX icon
557
Viking Therapeutics
VKTX
$3.88B
$976K 0.02%
121,747
-135,293
-53% -$986K
HHH icon
558
Howard Hughes
HHH
$3.94B
$975K 0.02%
8,063
+668
+9% +$74.1K
EHC icon
559
Encompass Health
EHC
$11.3B
$972K 0.02%
+17,629
New +$957K
ANIK icon
560
Anika Therapeutics
ANIK
$215M
$971K 0.01%
18,719
-5,192
-22% -$302K
EGRX
561
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$970K 0.01%
16,144
-7,858
-33% -$469K
LSI
562
DELISTED
Life Storage, Inc.
LSI
$962K 0.01%
13,322
+1,106
+9% +$79K
HIW icon
563
Highwoods Properties
HIW
$3.79B
$957K 0.01%
19,565
+1,624
+9% +$75.1K
WBS icon
564
Webster Financial
WBS
$12.3B
$957K 0.01%
17,932
+582
+3% +$28K
Z icon
565
Zillow
Z
$7.78B
$944K 0.01%
20,541
+1,893
+10% +$70.5K
SHOO icon
566
Steven Madden
SHOO
$3.17B
$943K 0.01%
+21,927
New +$885K
CIT
567
DELISTED
CIT Group Inc.
CIT
$941K 0.01%
20,619
+2,144
+12% +$96K
JBGS
568
JBG SMITH
JBGS
$846M
$938K 0.01%
23,514
+1,952
+9% +$77.2K
AMAG
569
DELISTED
AMAG Pharmaceuticals
AMAG
$933K 0.01%
76,693
-52,015
-40% -$568K
JEF icon
570
Jefferies Financial Group
JEF
$12.7B
$928K 0.01%
45,401
+3,590
+9% +$67.9K
PNFP icon
571
Pinnacle Financial Partners Inc
PNFP
$15.8B
$920K 0.01%
14,378
-20,763
-59% -$1.25M
SRC
572
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$919K 0.01%
18,683
+2,736
+17% +$136K
ATNX
573
DELISTED
Athenex, Inc. Common Stock
ATNX
$919K 0.01%
3,011
-4,068
-57% -$1.08M
HEI icon
574
HEICO Corp
HEI
$49.6B
$898K 0.01%
7,869
+3,263
+71% +$402K
WTI icon
575
W&T Offshore
WTI
$525M
$896K 0.01%
161,223
-78,493
-33% -$349K

Similar funds

Rafferty Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Rafferty Asset Management held 925 positions worth $6.5B, up 1.7% from $6.39B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Rafferty Asset Management withdrew a net $484M in Q4 2019, closing 61 positions and reducing 289 holdings. Its most notable exit was State Street Health Care Select Sector SPDR ETF, an estimated $83.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Rafferty Asset Management opened a new position in Moderna worth $3.18M.

  • Rafferty Asset Management's largest Q4 2019 buy was Moderna: 162,744 shares worth $3.18M.
  • Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q4 2019, an estimated $56.2M increase.
  • Rafferty Asset Management's biggest Q4 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $94.9M.
  • Rafferty Asset Management fully exited State Street Health Care Select Sector SPDR ETF in Q4 2019, selling an estimated $83.7M.
  • Rafferty Asset Management's ten largest holdings make up 53% of its $6.5B portfolio in Q4 2019.
  • Rafferty Asset Management opened 127 new positions and closed 61 in Q4 2019.
  • Rafferty Asset Management's portfolio value rose 1.7% quarter-over-quarter to $6.5B.

Based on Rafferty Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.